xtx301
·Code: XTX301
xtx301: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Xilio Therapeutics, Inc. (XLO) | Phase 1/Phase 2 |
Clinical Trials (1)
A First-in-Human, Multicenter, Phase 1/2, Open-Label Study of XTX301 in Patients With Advanced Solid Tumors
Frequently asked questions
Who is developing xtx301?
xtx301 is being developed by Xilio Therapeutics, Inc..
How many clinical trials involve xtx301?
BioSniper tracks 1 clinical trial involving xtx301.
Get deeper analysis on xtx301
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis